CURRENT APPROACHES TO PHARMACOTHERAPY OF STREPTOCOCCUS-ASSOCIATED GUTTATE PSORIASIS

The efficiency of using Clarithromycin, Linex and Essentiale forte in the combined therapy of streptococcus-associated guttate psoriasis in 27 patients has been studied. Decrease in antistreptolysin O titer, ADNs B in the blood and PASI index within three months and normal values of these indices within six months of follow-up examination have been established. Conventional therapy (without Clarithromycin, Linex and Essentiale forte) carried out in 20 patients with streptococcus- associated guttate psoriasis for comparison did not result in normalized levels of streptolysin O and streptodornase B antibodies as well as PASI index.